查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1941359

肺部標記市場報告：按癌症類型、標記類型、最終用戶和地區分類（2026-2034 年）

Lung Marker Market Report by Cancer Type (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)), Marker Type (EGFR, EML4-ALK, KRAS, BRAF, and Others), End User (Hospitals, Diagnostic Labs, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2025年全球肺部標記市場規模達5.285億美元。展望未來，IMARC Group預測，到2034年，市場規模將達到11.685億美元，2026年至2034年的複合年成長率為8.8%。

通常，肺部標記主要分為四類：EGFR、EML4-ALK、KRAS 和 BRAF。這些標記用於肺部介入治療、肺部手術和診斷。此外，它們還用於腫瘤的檢測、診斷、預後和後續觀察，並根據檢測結果為患者制定治療方案。肺部標記僅作為輔助工具，需與多種影像檢查和切片檢查相結合才能確診癌症。因此，肺部標記廣泛應用於包括醫院、門診手術中心和專科診所在內的各種醫療機構的胸腔鏡手術中。

肺部標記需求的不斷成長，源於呼吸系統疾病（如胸腔積液、胸膜間皮瘤和胸膜斑塊）發病率的上升，而這些疾病的發生又與全球日益嚴重的空氣污染密切相關。此外，被動吸煙的高暴露率和肺癌家族病史進一步增加了肺癌患者的數量，進一步推動了對肺部標記的需求。同時，人口快速老化和快節奏的消費生活方式導致的高吸菸率，也加劇了多種呼吸系統疾病的風險。此外，各國政府不斷增加醫療保健支出，用於肺癌等危及生命的疾病的早期診斷和治療，也推動了肺部標記在全球範圍內的應用。此外，對肺癌診斷和治療領域研發投入的增加，也進一步推動了對肺部標記的需求。肺部標記在醫院、手術中心和診所的廣泛應用，以及其多樣化的治療用途，也推動了相關產品的需求。

本報告解答的關鍵問題：

  • 目前全球肺部標記市場的發展趨勢如何？未來幾年預計發展如何？
  • 新冠疫情對全球肺部標記市場產生了哪些影響？
  • 你們的主要市場區域有哪些？
  • 按癌症類型分類的市場組成是什麼？
  • 依標記類型分類的市場區隔如何？
  • 依最終用戶分類的市場區隔如何？
  • 產業價值鏈包含哪些階段？
  • 該行業的主要促進因素和挑戰是什麼？
  • 全球肺部標記市場的結構是怎麼樣的？主要參與者有哪些？
  • 您所在產業的競爭程度如何？

目錄

第1章：序言

第2章：調查範圍與調查方法

  • 調查目標
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 調查方法

第3章執行摘要

第4章 引言

第5章：全球肺部標記市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 按癌症類型分類的市場區隔

  • 非小細胞肺癌（NSCLC）
  • 小細胞肺癌（SCLC）

第7章 按標記類型分類的市場區隔

  • EGFR
  • EML4-ALK
  • KRAS
  • BRAF
  • 其他

第8章 按最終用戶分類的市場細分

  • 醫院
  • 診斷檢查室
  • 其他

第9章 按地區分類的市場細分

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他
  • 中東和非洲
    • 土耳其
    • 伊朗
    • 其他

第10章 SWOT 分析

第11章 價值鏈分析

第12章 波特五力分析

第13章 價格指標

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc
    • Agilent Technologies, Inc.
    • Beckman Coulter, Inc.
    • Fujirebio Europe NV
    • Hologic, Inc.
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers
    • BioSpace, Inc.
Product Code: SR112026A2063

The global lung marker market size reached USD 528.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,168.5 Million by 2034, exhibiting a growth rate (CAGR) of 8.8% during 2026-2034.

Generally, four major types of lung markers, including EGFR, EML4-ALK, KRAS, and BRAF, are used during lung intervention procedures or lung surgeries and diagnosis. Furthermore, the markers are used to detect, diagnose, predict, and monitor the tumor, based on which the treatment is prescribed to the patient. Lung markers are only used as an additional tool to identify cancer along with several imaging tests and biopsy. Owing to this, lung markers are extensively used in thoracoscopic surgeries across hospitals, ambulatory surgical clinics, and specialty clinics, among several other healthcare facilities.

The rising demand for lung markers can be attributed to the high prevalence of respiratory disorders, such as pleural effusion, pleural mesothelioma, pleural plaque, etc., due to the increasing air pollution levels, across the globe. Besides this, the high exposure to passive smoking, along with a family history of lung cancer further drives the number of patients suffering from lung cancer, thereby augmenting the demand for lung markers. Additionally, the surging geriatric population, along with the hectic consumer lifestyles leading to a high smoking rate, further accelerate the risks of several respiratory disorders. Apart from this, the increasing healthcare expenditures by various governments for early diagnosis and pre-treatment of life-threatening diseases, such as lung cancer, are also propelling the rising utilization of lung markers at a global level. Furthermore, rising investments in several research and development activities in the field of lung cancer diagnostics and treatment is further catalyzing the demand for lung markers. In addition to this, the increasing usage of lung markers in hospitals, surgery centers, clinics, and their various applications in therapeutic purposes has also catalyzed the product demand.

Key Market Segmentation:

Breakup by Cancer Type:

  • Non-Small Cell Lung Cancer (NSCLC)
  • Small Cell Lung Cancer (SCLC)

Breakup by Marker Type:

  • EGFR
  • EML4-ALK
  • KRAS
  • BRAF
  • Others

Breakup by End User:

  • Hospitals
  • Diagnostic Labs
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Others
  • Middle East and Africa
    • Turkey
    • Iran
    • Others

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Beckman Coulter, Inc., Fujirebio Europe N.V., Hologic, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers, and BioSpace, Inc.

Key Questions Answered in This Report:

  • How has the global lung marker market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global lung marker market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the marker type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global lung marker market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Lung Marker Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact Of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Cancer Type

  • 6.1 Non-Small Cell Lung Cancer (NSCLC)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Small Cell Lung Cancer (SCLC)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Marker Type

  • 7.1 EGFR
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 EML4-ALK
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 KRAS
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 BRAF
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Labs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Germany
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 France
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 United Kingdom
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 Italy
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Spain
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Russia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 China
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 Japan
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 India
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 South Korea
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Australia
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Indonesia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Argentina
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
    • 9.4.4 Colombia
      • 9.4.4.1 Market Trends
      • 9.4.4.2 Market Forecast
    • 9.4.5 Chile
      • 9.4.5.1 Market Trends
      • 9.4.5.2 Market Forecast
    • 9.4.6 Peru
      • 9.4.6.1 Market Trends
      • 9.4.6.2 Market Forecast
    • 9.4.7 Others
      • 9.4.7.1 Market Trends
      • 9.4.7.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Turkey
      • 9.5.1.1 Market Trends
      • 9.5.1.2 Market Forecast
    • 9.5.2 Iran
      • 9.5.2.1 Market Trends
      • 9.5.2.2 Market Forecast
    • 9.5.3 Others
      • 9.5.3.1 Market Trends
      • 9.5.3.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Thermo Fisher Scientific Inc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Agilent Technologies, Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Beckman Coulter, Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Fujirebio Europe N.V.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Hologic, Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 F. Hoffmann-La Roche Ltd
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Siemens Healthineers
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 BioSpace, Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis

List of Figures

  • Figure 2: Global: Lung Marker Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Lung Marker Market: Breakup by Cancer Type (in %), 2025
  • Figure 4: Global: Lung Marker Market: Breakup by Marker Type (in %), 2025
  • Figure 5: Global: Lung Marker Market: Breakup by End User (in %), 2025
  • Figure 6: Global: Lung Marker Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 8: Global: Lung Marker (NSCLC) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Lung Marker (NSCLC) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Lung Marker (SCLC) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Lung Marker (SCLC) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Lung Marker (EGFR) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Lung Marker (EGFR) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Lung Marker (EML4-ALK) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Lung Marker (EML4-ALK) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Lung Marker (KRAS) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Lung Marker (KRAS) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Lung Marker (BRAF) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Lung Marker (BRAF) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Lung Marker (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Lung Marker (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Lung Marker (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Lung Marker (Diagnostic Labs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Lung Marker (Diagnostic Labs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Lung Marker (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: North America: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: North America: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: United States: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: United States: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Canada: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Canada: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Asia Pacific: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Asia Pacific: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: China: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: China: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Japan: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Japan: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: India: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: India: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: South Korea: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: South Korea: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Australia: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Australia: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Indonesia: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Indonesia: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Others: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Others: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Europe: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Europe: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Germany: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Germany: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: France: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: France: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: United Kingdom: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: United Kingdom: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Italy: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Italy: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Spain: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Spain: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Russia: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Russia: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Others: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Others: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Middle East and Africa: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Middle East and Africa: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Turkey: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Turkey: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Iran: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Iran: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Others: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Others: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Latin America: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Latin America: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Brazil: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Brazil: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Mexico: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Mexico: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Argentina: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Argentina: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Colombia: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Colombia: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Chile: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Chile: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Peru: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Peru: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Others: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 89: Others: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 90: Global: Lung Marker Industry: SWOT Analysis
  • Figure 91: Global: Lung Marker Industry: Value Chain Analysis
  • Figure 92: Global: Lung Marker Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Lung Marker Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Lung Marker Market Forecast: Breakup by Cancer Type (in Million USD), 2026-2034
  • Table 3: Global: Lung Marker Market Forecast: Breakup by Marker Type (in Million USD), 2026-2034
  • Table 4: Global: Lung Marker Market Forecast: Breakup by End Use (in Million USD), 2026-2034
  • Table 5: Global: Lung Marker Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Lung Marker Market: Competitive Structure
  • Table 7: Global: Lung Marker Market: Key Players